Invivyd Inc (IVVD)
1.58
-0.12
(-7.06%)
USD |
NASDAQ |
Jun 14, 16:00
1.58
0.00 (0.00%)
After-Hours: 20:00
Invivyd Cash from Operations (TTM): -182.20M for March 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -182.20M |
December 31, 2023 | -173.16M |
September 30, 2023 | -161.33M |
June 30, 2023 | -182.12M |
March 31, 2023 | -202.12M |
Date | Value |
---|---|
December 31, 2022 | -219.99M |
September 30, 2022 | -245.80M |
June 30, 2022 | -243.87M |
March 31, 2022 | -220.04M |
December 31, 2021 | -184.74M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-245.80M
Minimum
Sep 2022
-161.33M
Maximum
Sep 2023
-201.54M
Average
-193.43M
Median
Cash from Operations (TTM) Benchmarks
Vanda Pharmaceuticals Inc | -11.43M |
Viking Therapeutics Inc | -54.87M |
Stoke Therapeutics Inc | -84.28M |
180 Life Sciences Corp | -8.086M |
MAIA Biotechnology Inc | -13.30M |